ELV
Strong BuyFull HouseAPPROVEElevance Health, Inc. · Healthcare · United States · $85.5B · Avg Vol: $427M/d
Full House: Strong business, sensible price, market agrees. The rare full house.
Elevance Health clears the calibrated bar. All three legs are above the floor (Q58 V64 M62) and a buyback across two filing days retiring 3.50% of shares outstanding provides substantial corroboration, one of the larger capital returns in this batch. Nothing adverse survives the evidence test: both insider figures on file, a purchase and a sale, round to 0.00% of shares outstanding and are therefore treated as unusable in either direction rather than as adverse, and there is no negative earnings revision.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT ELEVANCE HEALTH, INC.
Read
Elevance Health, Inc. is a leading health benefits company in the United States, offering a comprehensive suite of health insurance plans and related services through its Anthem Blue Cross Blue Shield affiliated plans and other brands. The company leverages its immense scale, extensive provider networks, and brand recognition to deliver integrated healthcare solutions to millions of members. Its diversified services, including pharmacy benefits management, strengthen its competitive moat in the evolving healthcare landscape.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 156.6B | 171.3B | 176.8B | 199.1B | 8.3% | 201.1B | 197.8B | 202.0B | 0.7% |
| EPS | 25.32 | 25.69 | 26.29 | 25.65 | 0.4% | 22.62 | 23.00 | 25.07 | -1.1% |
| Shares | 238.0M | 233.1M | 227.5M | 220.7M | -7.2% | 216.9M | — | — | — |
| Debt | 24.1B | 25.1B | 31.2B | 32.0B | 9.9% | 31.0B | — | — | — |
| Equity | 36.2B | 39.3B | 41.3B | 43.9B | 6.6% | — | — | — | — |
| Op CF | 8.4B | 8.1B | 5.8B | 4.3B | -20.1% | 7.5B | — | — | — |
| Inv CF | -4.6B | -5.6B | -5.2B | -1.3B | — | — | — | — | — |
| Fin CF | -1.3B | -3.3B | 1.2B | -1.7B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ELV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ELV | Elevance Health, Inc.(you) | $85.5B | 90 | Strong Buy |
| CI | The Cigna Group | $73.7B | 92 | Strong Buy |
| CVS | CVS Health Corporation | $119.0B | 93 | Strong Buy |
| HUM | Humana Inc. | $46.3B | 89 | Strong Buy |
| CNC | Centene Corporation | $32.0B | 93 | Strong Buy |
| UNH | UnitedHealth Group Incorporated | $352.7B | 90 | Strong Buy |
| OSCR | Oscar Health, Inc. | $9.4B | 98 | Strong Buy |
| SAUD3.SA | Bradsaúde S.A. | $7.9B | 98 | Strong Buy |
| MOH | Molina Healthcare, Inc. | $10.4B | 71 | Buy |
| PGNY | Progyny, Inc. | $2.0B | 98 | Strong Buy |
Peer medians: ROE 2.7% · P/E 23.6x · Gross margin 52.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.